Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health”

1,166 pharma patents match "The United States of America, as represented by the Secretary, Department of Health" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,166
Index total 30,257
Page 33 / 49

Quick answer

This filtered view shows 1,166 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,166 results for “The United States of America, as represented by the Secretary, Department of Health” · 30,257 patents in full index Clear search

  1. US 9486502

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  2. US 9487573

    Murine anti-NY-ESO-1 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  3. US 9487563

    Virus-like particles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  4. US 9481866

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  5. US 9474796

    Crimean-Congo hemorrhagic fever virus vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  6. US 9474795

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  7. US 9475862

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  8. US 9475839

    Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  9. US 9468208

    Disease control with tick phospholipase A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted

  10. US 9464035

    Salicylic acid derivatives useful as glucocerebrosidase activators

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  11. US 9463233

    Avirulent, immunogenic flavivirus chimeras

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2016 · Expires Oct 6, 2036

    granted

  12. US 9458141

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  13. US 9457132

    Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  14. US 9452973

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  15. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  16. US 9447144

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  17. US 9446048

    Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  18. US 9441019

    Influenza hemagglutinin protein-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  19. US 9441041

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  20. US 9441022

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  21. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  22. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  23. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  24. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.